This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Michael Kelley: Innovator in Interferon-Like Proteins
Introduction
Michael Kelley is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of interferon-like proteins. His work has implications for the diagnosis and treatment of various diseases.
Latest Patents
Kelley holds a patent for "Interferon-like proteins and uses thereof." This invention provides Interferon-Like (IFN-L) polypeptides and nucleic acid molecules encoding the same. The patent also includes selective binding agents, vectors, host cells, and methods for producing IFN-L polypeptides. Furthermore, it offers pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases associated with IFN-L polypeptides. He has 1 patent to his name.
Career Highlights
Michael Kelley is currently employed at Amgen Inc., a leading biotechnology company. His role involves research and development in the field of protein therapeutics. His innovative work has contributed to advancements in medical treatments.
Collaborations
Kelley has collaborated with notable colleagues, including Andrew A Welcher and Duanzhi Wen. These partnerships have enhanced the research and development efforts in his field.
Conclusion
Michael Kelley is a prominent inventor whose work on interferon-like proteins has the potential to impact medical science significantly. His contributions to biotechnology continue to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile